Explore

Trendline Trendline
Schrödinger to Engage Investors at May 2026 Conferences

Schrödinger to Engage Investors at May 2026 Conferences

Schrödinger to Engage Investors at May 2026 Conferences
Trendline Trendline
Schrödinger to Engage Investors at Upcoming Healthcare Conferences

Schrödinger to Engage Investors at Upcoming Healthcare Conferences

Schrödinger to Engage Investors at Upcoming Healthcare Conferences
Trendline Trendline
Summit Shares Plummet as Cancer Drug Fails Early Survival Benchmark

Summit Shares Plummet as Cancer Drug Fails Early Survival Benchmark

Summit Shares Plummet as Cancer Drug Fails Early Survival Benchmark
Trendline Trendline
Twist Bioscience Reports Fiscal 2026 Q2 Financial Results Highlighting Growth

Twist Bioscience Reports Fiscal 2026 Q2 Financial Results Highlighting Growth

Twist Bioscience Reports Fiscal 2026 Q2 Financial Results Highlighting Growth
Reuters Reuters
KKR-backed GMR eyes $5 billion valuation in US IPO

KKR-backed GMR eyes $5 billion valuation in US IPO

May 4 (Reuters) - Emergency medical services GMR Solutions said on Monday it was targeting a valuation of up to $5 billion in its U.S. initial public offering, as the pickup in new listings extends into May.
Trendline Trendline
Nuvectis Pharma Reports Increased Net Loss in Q1 2026 Amid Clinical Expansion

Nuvectis Pharma Reports Increased Net Loss in Q1 2026 Amid Clinical Expansion

Nuvectis Pharma Reports Increased Net Loss in Q1 2026 Amid Clinical Expansion
Trendline Trendline
Lunai Bioworks Completes $20 Million Equity Issuance to Expand CNS Platform

Lunai Bioworks Completes $20 Million Equity Issuance to Expand CNS Platform

Lunai Bioworks Completes $20 Million Equity Issuance to Expand CNS Platform
Trendline Trendline
Odyssey Therapeutics Sets Terms for $225 Million IPO Amid Resurgent Biotech Market

Odyssey Therapeutics Sets Terms for $225 Million IPO Amid Resurgent Biotech Market

Odyssey Therapeutics Sets Terms for $225 Million IPO Amid Resurgent Biotech Market
Trendline Trendline
IQVIA Exceeds Q1 Sales Estimates, Raises Full-Year Guidance

IQVIA Exceeds Q1 Sales Estimates, Raises Full-Year Guidance

IQVIA Exceeds Q1 Sales Estimates, Raises Full-Year Guidance
Trendline Trendline
Senstar Technologies Files 2025 Annual Report with SEC

Senstar Technologies Files 2025 Annual Report with SEC

Senstar Technologies Files 2025 Annual Report with SEC
Trendline Trendline
Travere Therapeutics Reports Significant Growth in Q1 2026 Financial Results

Travere Therapeutics Reports Significant Growth in Q1 2026 Financial Results

Travere Therapeutics Reports Significant Growth in Q1 2026 Financial Results
Trendline Trendline
Galantas Gold to Present at Virtual Investor Conference Amid Expansion Plans

Galantas Gold to Present at Virtual Investor Conference Amid Expansion Plans

Galantas Gold to Present at Virtual Investor Conference Amid Expansion Plans